
GC12910
Canertinib
Also listed as Canertinib (CI-1033)
Canertinib (CI-1033) (CI-1033;PD-183805) is a potent and irreversible EGFR inhibitor; inhibits cellular EGFR and ErbB2 autophosphorylation with IC50s of 7·4 and 9 nM
ChemicalCAS267243-28-7MW485.94FormulaC24H25ClFN5O3
- CAS number
- 267243-28-7
- Molecular weight
- 485.94
- Formula
- C24H25ClFN5O3
- Solubility
- ≥ 12·15mg/mL in DMSO with gentle warming
- InChIKey
- OMZCMEYTWSXEPZ-UHFFFAOYSA-N
- Catalogue number
- GC12910
- Brand
- GLPBIO
Computed properties PubChem CID 156414 · XLogP 3.9 · TPSA 88.6 Ų · H-bond donors 2
- XLogP
- 3.9
- TPSA
- 88.6 Ų
- H-bond donors
- 2
- H-bond acceptors
- 8
- Rotatable bonds
- 9
- Heavy atoms
- 34
SMILES C=CC(=O)NC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4
Computed descriptors from PubChem (CID 156414), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il